AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
FLT3 SIGNALING IN HEMATOPOIETIC-CELLS INVOLVES CBL, SHC AND AN UNKNOWN P115 AS PROMINENT TYROSINE-PHOSPHORYLATED SUBSTRATES
Authors: LAVAGNASEVENIER C MARCHETTO S BIRNBAUM D ROSNET O
Citation: C. Lavagnasevenier et al., FLT3 SIGNALING IN HEMATOPOIETIC-CELLS INVOLVES CBL, SHC AND AN UNKNOWN P115 AS PROMINENT TYROSINE-PHOSPHORYLATED SUBSTRATES, Leukemia, 12(3), 1998, pp. 301-310
COCKTAIL THERAPY FOR CHRONIC HEPATITIS-C - PRELIMINARY-RESULTS
Authors: MARCHETTO S FABBRI C MAZZEO C COLEECHIA A FESTI D AZZAROLI F RODA E MAZZELLA G
Citation: S. Marchetto et al., COCKTAIL THERAPY FOR CHRONIC HEPATITIS-C - PRELIMINARY-RESULTS, Hepatology, 28(4), 1998, pp. 194-194
GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY
Authors: FABBRI C JABOLI MF MAZZELLA G SOTTILI S MARCHETTO S PEZZOLI A ECCOGLI E RODA E
Citation: C. Fabbri et al., GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY, Hepatology, 28(4), 1998, pp. 2189-2189
THE CBL-RELATED PROTEIN CBLB PARTICIPATES IN FLT3 AND INTERLEUKIN-7 RECEPTOR SIGNAL-TRANSDUCTION IN PRO-B CELLS
Authors: LAVAGNASEVENIER C MARCHETTO S BIRNBAUM D ROSNET O
Citation: C. Lavagnasevenier et al., THE CBL-RELATED PROTEIN CBLB PARTICIPATES IN FLT3 AND INTERLEUKIN-7 RECEPTOR SIGNAL-TRANSDUCTION IN PRO-B CELLS, The Journal of biological chemistry, 273(24), 1998, pp. 14962-14967
THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO ALPHA-INTERFERON TREATMENT IS ASSOCIATED WITH ITS DECREASE
Authors: ACCOGLI E TRERE D MAZZELLA G COLECCHIA A SOTTILI S CASANOVA S MARCHETTO S FABBRI C JABOLI F FESTI D RODA E DERENZINI M
Citation: E. Accogli et al., THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO ALPHA-INTERFERON TREATMENT IS ASSOCIATED WITH ITS DECREASE, Gastroenterology, 114(4), 1998, pp. 3-3
GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY
Authors: FABBRI C JABOLI MF MAZZELLA G SOTTILI S MARCHETTO S PEZZOLI A ACCOGLI E RODA E
Citation: C. Fabbri et al., GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY, Gastroenterology, 114(4), 1998, pp. 164-164
THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO IFN TREATMENT IS ASSOCIATED WITH ITS DECREASE
Authors: ACCOGLI E TRERE D MAZZELLA G COLECCHIA A SOTTILI S CASANOVA S MARCHETTO S FABBRI C JABOLI F FESTI D RODA E DERENZINI M
Citation: E. Accogli et al., THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO IFN TREATMENT IS ASSOCIATED WITH ITS DECREASE, Hepatology, 26(4), 1997, pp. 722-722
EFFICACY OF URSODEOXYCHOLIC ACID ADMINISTRATION AS ADJUVANT THERAPY TOGETHER WITH ALFA-INTERFERON FOR CHRONIC HEPATITIS-C
Authors: FABBRI C MAZZELLA G MARCHETTO S PEZZOLI A ACCOGLI E FUSAROLI P AZZAROLI F MAZZEO C JABOLI F SOTTILI S RODA E
Citation: C. Fabbri et al., EFFICACY OF URSODEOXYCHOLIC ACID ADMINISTRATION AS ADJUVANT THERAPY TOGETHER WITH ALFA-INTERFERON FOR CHRONIC HEPATITIS-C, Gut, 41, 1997, pp. 131-131
THE EFFICACY OF BETA-IFN IN PATIENTS ALPHA-IFN NONRESPONDERS PATIENTS
Authors: MARCHETTO S MAZZELLA G MAZZEO C PEZZOLI A CIRIACI AM RODA E
Citation: S. Marchetto et al., THE EFFICACY OF BETA-IFN IN PATIENTS ALPHA-IFN NONRESPONDERS PATIENTS, Gut, 41, 1997, pp. 131-131
HISTOLOGICAL AND CLINICAL OUTCOME OF HCV LIVER TRANSPLANTED PATIENTS
Authors: MORELLI MC POLIFEMO AM MIMMO RA DEVERGON E CASANOVA S MAZZCO C MARCHETTO S RODA E
Citation: Mc. Morelli et al., HISTOLOGICAL AND CLINICAL OUTCOME OF HCV LIVER TRANSPLANTED PATIENTS, Gut, 41, 1997, pp. 239-239
INTERFERON-ALFA VERSUS SILIBININA PLUS INTERFERON IN CHRONIC HEPATITIS-C PREVIOUSLY RESISTANT TO INTERFERON - A RANDOMIZED TRIAL
Authors: CIRACI AM MAZZELLA G MAZZEO C GAMBERINI S BOCCIA S FERRARI L BELLONI G MARCHETTO S RODA E
Citation: Am. Ciraci et al., INTERFERON-ALFA VERSUS SILIBININA PLUS INTERFERON IN CHRONIC HEPATITIS-C PREVIOUSLY RESISTANT TO INTERFERON - A RANDOMIZED TRIAL, Gastroenterology, 112(4), 1997, pp. 1246-1246
EFFICACY OF URSODEOXYCHOLIC ACID ADMINISTRATION AS ADJUVANT THERAPY TOGETHER WITH ALFA-INTERFERON FOR CHRONIC HEPATITIS-C
Authors: FABBRI C MAZZELLA G MARCHETTO S PEZZOLI A FUSAROLI P ACCOGLI E AZZAROLI F MAZZEO C JABOLI F RODA E
Citation: C. Fabbri et al., EFFICACY OF URSODEOXYCHOLIC ACID ADMINISTRATION AS ADJUVANT THERAPY TOGETHER WITH ALFA-INTERFERON FOR CHRONIC HEPATITIS-C, Gastroenterology, 112(4), 1997, pp. 1261-1261
FUNCTIONAL AND PHENOTYPIC CHARACTERIZATION OF CORD-BLOOD AND BONE-MARROW SUBSETS EXPRESSING FLT3 (CD135) RECEPTOR TYROSINE KINASE
Authors: RAPPOLD I ZIEGLER BL KOHLER I MARCHETTO S ROSNET O BIRNBAUM D SIMMONS PJ ZANNETTINO ACW HILL B NEU S KNAPP W ALITALO R ALITALO K ULLRICH A KANZ L BUHRING HJ
Citation: I. Rappold et al., FUNCTIONAL AND PHENOTYPIC CHARACTERIZATION OF CORD-BLOOD AND BONE-MARROW SUBSETS EXPRESSING FLT3 (CD135) RECEPTOR TYROSINE KINASE, Blood, 90(1), 1997, pp. 111-125
HUMAN FLT3 FLK2 RECEPTOR TYROSINE KINASE IS EXPRESSED AT THE SURFACE OF NORMAL AND MALIGNANT HEMATOPOIETIC-CELLS/
Authors: ROSNET O BUHRING HJ MARCHETTO S RAPPOLD I LAVAGNA C SAINTY D AMOULET C CHABANNON C KANZ L HANNUM C BIRNBAUM D
Citation: O. Rosnet et al., HUMAN FLT3 FLK2 RECEPTOR TYROSINE KINASE IS EXPRESSED AT THE SURFACE OF NORMAL AND MALIGNANT HEMATOPOIETIC-CELLS/, Leukemia, 10(2), 1996, pp. 238-248
GLICLAZIDE POTENTIATES SUPPRESSION OF HEPATIC GLUCOSE-PRODUCTION IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
Authors: RICCIO A LISATO G DEKREUTZENBERG SV MARCHETTO S TURRIN M TIENGO A DELPRATO S
Citation: A. Riccio et al., GLICLAZIDE POTENTIATES SUPPRESSION OF HEPATIC GLUCOSE-PRODUCTION IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS, Metabolism, clinical and experimental, 45(10), 1996, pp. 1196-1202
INTERACTION WITH THE PHOSPHOTYROSINE BINDING DOMAIN PHOSPHOTYROSINE INTERACTING DOMAIN OF SHC IS REQUIRED FOR THE TRANSFORMING ACTIVITY OF THE FLT4/VEGFR3 RECEPTOR TYROSINE KINASES/
Authors: FOURNIER E ROSNET O MARCHETTO S TURCK CW ROTTAPEL R PELICCI PG BIRNBAUM D BORG JP
Citation: E. Fournier et al., INTERACTION WITH THE PHOSPHOTYROSINE BINDING DOMAIN PHOSPHOTYROSINE INTERACTING DOMAIN OF SHC IS REQUIRED FOR THE TRANSFORMING ACTIVITY OF THE FLT4/VEGFR3 RECEPTOR TYROSINE KINASES/, The Journal of biological chemistry, 271(22), 1996, pp. 12956-12963
BETA-IFN ADMINISTRATION IN PATIENTS WITH CHRONIC HEPATITIS-C NONRESPONDERS TO A PREVIOUS ALPHA-IFN CYCLE
Authors: MARCHETTO S MAZZELLA G MAZZEO C RODA E
Citation: S. Marchetto et al., BETA-IFN ADMINISTRATION IN PATIENTS WITH CHRONIC HEPATITIS-C NONRESPONDERS TO A PREVIOUS ALPHA-IFN CYCLE, Gastroenterology, 110(4), 1996, pp. 1257-1257
PREDICTIVE FACTORS OF RESPONSE IN ALPHA-INTERFERON TREATED HEPATITIS-C - RESULTS AFTER 2 YEARS OF FOLLOW-UP
Authors: MAZZELLA G NOVELLI V CIRIACI AM CIPOLLA A MARCHETTO S SOTTILI S RODA E
Citation: G. Mazzella et al., PREDICTIVE FACTORS OF RESPONSE IN ALPHA-INTERFERON TREATED HEPATITIS-C - RESULTS AFTER 2 YEARS OF FOLLOW-UP, Gastroenterology, 110(4), 1996, pp. 1263-1263
LONG-TERM OUTCOME OF INTERFERON THERAPY IN CHRONIC TYPE-B HEPATITIS -IS NATURAL-HISTORY MODIFIED
Authors: MAZZELLA G SARACCO G MARCHETTO S ROSINA F CIPOLLA A JABOLI F VERME G MINIERO R CANCELLIERI C FESTI D SOTTILI S RODA E RIZZETTO M
Citation: G. Mazzella et al., LONG-TERM OUTCOME OF INTERFERON THERAPY IN CHRONIC TYPE-B HEPATITIS -IS NATURAL-HISTORY MODIFIED, Gastroenterology, 110(4), 1996, pp. 1263-1263
EFFECT OF COMBINATION THERAPY WITH IMMUNOSUPPRESSORS AND UDCA IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS
Authors: MAZZELLA G PEZZOLI A FUSAROLI P MARCHETTO S CIPOLLA A RODA E
Citation: G. Mazzella et al., EFFECT OF COMBINATION THERAPY WITH IMMUNOSUPPRESSORS AND UDCA IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS, Gastroenterology, 110(4), 1996, pp. 1263-1263
BASAL INSULIN MODULATES GLUCOSE-MEDIATED GLUCOSE-METABOLISM IN TYPE-2DIABETIC-PATIENTS (NIDDM)
Authors: DELPRATO S MARCHETTO S DEKREUTZENBERG SV ZANON M MARESCOTTI MC TIENGO A
Citation: S. Delprato et al., BASAL INSULIN MODULATES GLUCOSE-MEDIATED GLUCOSE-METABOLISM IN TYPE-2DIABETIC-PATIENTS (NIDDM), Diabetologia, 39, 1996, pp. 681-681
EXPRESSION AND SIGNAL-TRANSDUCTION OF THE FLT3 TYROSINE KINASE RECEPTOR
Authors: ROSNET O BUHRING HJ DELAPEYRIERE O BESLU N LAVAGNA C MARCHETTO S RAPPOLD I DREXLER HG BIRG F ROTTAPEL R HANNUM C DUBREUIL P BIRNBAUM D
Citation: O. Rosnet et al., EXPRESSION AND SIGNAL-TRANSDUCTION OF THE FLT3 TYROSINE KINASE RECEPTOR, Acta haematologica, 95(3-4), 1996, pp. 218-223
METFORMIN AND FREE FATTY-ACID METABOLISM
Authors: DELPRATO S MARCHETTO S PIPITONE A ZANON M DEKREUTZENBERG SV TIENGO A
Citation: S. Delprato et al., METFORMIN AND FREE FATTY-ACID METABOLISM, Diabetes/metabolism reviews, 11, 1995, pp. 33-41
EXPRESSION OF FLT3 TYROSINE KINASE RECEPTOR GENE IN MOUSE HEMATOPOIETIC AND NERVOUS TISSUES
Authors: DELAPEYRIERE O NAQUET P PLANCHE J MARCHETTO S ROTTAPEL R GAMBARELLI D ROSNET O BIRNBAUM D
Citation: O. Delapeyriere et al., EXPRESSION OF FLT3 TYROSINE KINASE RECEPTOR GENE IN MOUSE HEMATOPOIETIC AND NERVOUS TISSUES, Differentiation, 58(5), 1995, pp. 351-359
IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL MURINE FLT3 ISOFORM PRODUCED BY EXON SKIPPING
Authors: LAVAGNA C MARCHETTO S BIRNBAUM D ROSNET O
Citation: C. Lavagna et al., IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL MURINE FLT3 ISOFORM PRODUCED BY EXON SKIPPING, The Journal of biological chemistry, 270(7), 1995, pp. 3165-3171
Risultati: 1-25 | 26-30